Illness | Page 78 of 96 | SpiritIndia.com

Psychiatry :: UCLA Faculty Recognized for Outstanding Achievement in Psychiatric Research

Three UCLA scientists will be awarded top prizes for psychiatric research on Friday by NARSAD: The Mental Health Research Association, the world’s largest donor-supported organization dedicated to funding innovative research on severe mental illnesses. Lori Altshuler, M.D.; Joaquin M. Fuster, M.D., Ph.D., and Tyrone D. Cannon, Ph.D., all of UCLA’s Semel Institute, will be presented their awards at NARSAD’s 19th annual ceremony in New York City.

Stress :: Better understanding post traumatic stress disorder PTSD

New research into Posttraumatic Stress Disorder (PTSD) is leading to a better understanding of its underlying neurobiology, risk factors and long-term implications. The findings are published in a recent issue of Annals of the New York Academy of Sciences and were revealed at a conference jointly sponsored by the New York Academy of Sciences and the Mount Sinai School of Medicine.

Leptospirosis :: Leptospirosis diagnosed after a fishing holiday in France

Leptospirosis has been diagnosed clinically in two men recently returned from a fishing holiday at a resort in the Picardie region of north-east France. One case has since been serologically confirmed. Both patients were at the same resort at the same time (mid-September), and became unwell about one week after their return to the United Kingdom.

Depression :: Association between depression and physical illnesses

Anxiety disorders are linked to physical illness. These physical problems include arthritis, migraine headaches, respiratory disease, allergies, thyroid disease, etc. The new study done by experts have found an association between depression and physical illness. Evidence of a link between anxiety and physical health was made according to information in this new research.

Pregnancy :: Flu vaccination for women in late pregnancy

Pregnant women are likely to be offered flu vaccination in the later stages of pregnancy because of the strain that the illness could put on their heart and lungs in childbirth. The move is likely to cause concern among some pregnant women who are already anxious about advice that is offered on what foods and medications are safe.

Heart Disease :: Healthy lifestyle with lower risk of myocardial infarction MI

Although moderate alcohol intake is associated with lower risk for myocardial infarction (MI), guidelines generally suggest that adults seek other lifestyle measures to reduce cardiovascular risk. Physical activity, smoking, and diet, moderate alcohol intake is associated with lower risk for MI.

Bipolar Depression :: AstraZeneca’s SEROQUEL for Bipolar Depression Treatment

AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has approved SEROQUEL? (quetiapine fumarate) for the treatment of patients with depressive episodes associated with bipolar disorder. SEROQUEL already is approved for the treatment of acute manic episodes associated with bipolar I disorder and for the treatment of schizophrenia. SEROQUEL is now the first and only single medication approved by the FDA to treat both depressive and manic episodes associated with bipolar disorder.

HIV :: REYATAZ, atazanavir sulfate for Adults With HIV-1 Infection

Bristol-Myers Squibb Company (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has granted approval of a new 300 mg single capsule formulation of REYATAZ? (atazanavir sulfate) for the treatment of HIV-1 infection in adults as part of combination therapy. Taken once daily along with ritonavir and food as part of a anti-HIV drug regimen, the REYATAZ 300 mg single capsule formulation can replace two REYATAZ 150 mg capsules for: patients who have previously received anti-HIV medicines, patients who will be receiving tenofovir disoproxil fumarate, and patients who have never taken anti-HIV medicines that require SUSTIVA? (efavirenz) as part of their anti-HIV drug regimen. The REYATAZ single capsule formulation will be available in the United States within seven business days.

Meningitis :: Meningitis shot and risk for Guillain Barre syndrome

Young people who get a new meningitis shot may be at a slightly higher risk of developing a paralyzing side effect, federal researchers said. Even so, U.S. health officials said the benefits far outweigh the risk of getting the rare condition, Guillain Barre syndrome. They are not backing off their recommendation that most students be vaccinated.

Influenza :: Novartis cell culture-derived influenza vaccine well tolerated and efficacious

Novartis (NYSE: NVS) announced today results of pivotal Phase III clinical trial data for its innovative cell culture-derived influenza vaccine demonstrating that it is highly capable of producing an immune response (“immunogenic”), one at least as strong as the traditional egg-derived influenza vaccine Aggripal? for each of the three influenza strains studied.